awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q26824086-E0B09FFA-FDA3-49A5-A482-5BE9F4C6F79E
Q26824086-E0B09FFA-FDA3-49A5-A482-5BE9F4C6F79E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26824086-E0B09FFA-FDA3-49A5-A482-5BE9F4C6F79E
The impact of Bevacizumab (Avastin) on survival in metastatic solid tumors--a meta-analysis and systematic review
P2860
Q26824086-E0B09FFA-FDA3-49A5-A482-5BE9F4C6F79E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26824086-E0B09FFA-FDA3-49A5-A482-5BE9F4C6F79E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a1327ff2ef5c97f9526ccb02a8653c69f37e8447
P2860
Phase III study of bevacizumab plus docetaxel compared with placebo plus docetaxel for the first-line treatment of human epidermal growth factor receptor 2-negative metastatic breast cancer.